First, we hypothesized that microglial deletion of A20, a negative regulator of NF-κB signaling that controls microglia inflammasome activation and CNS inflammation (37), may exacerbate ß-amyloid-induced neuroinflammation and AD outcomes (Supplementary Figure 1A). Here, NFKB1 is linked to Alzheimer disease.